跳至主要内容
临床试验/NCT03748147
NCT03748147Unknown不适用

Cervical Ripening in Obese Women: a Prospective, Randomized Trial Comparing Efficacy of 25 mcg Versus 50 mcg of Misoprostol

University of Cincinnati0 个研究点目标入组 300 人开始时间: 2018年12月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
300
主要终点
Vaginal delivery

研究概览

简要总结

This is a prospective clinical trial to determine if 50 mcg versus 25 mcg po every four hours of misoprostol has improved efficacy and similar safety in obese women undergoing cesarean section.

详细描述

We will perform a prospective, randomized, double-blind clinical trial with parallel assignment.

Obese women (delivery BMI 30 or more) who agree to participation will be randomly designated to receive either 25 mcg po q 4 hour (control) misoprosol versus 50 mcg po q 4 hours. Our primary outcome will be the rate of successful induction. Secondary outcomes will include ability to achieve a Bishop score greater than 7, time to active labor, and safety data including rate of tachysystole, non-reassuring fetal status, NICU admission.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

盲法说明

Both arms will receive identical appearing drug made by the Investigational Drug Unit of the Pharmacy.

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Labor induction, BMI of 30 or greater, English speaking

排除标准

  • Prior cesarean section, uterine tachysystole (5 contractions/ 10 minutes) on admission, Contraindication to labor induction

研究组 & 干预措施

Control

Active Comparator

Standard of care, misoprostol 25 mcg po every four hours

干预措施: Misoprostol (Drug)

Intervention

Experimental

Misoprostol 50 mcg po every four hours

干预措施: Misoprostol (Drug)

结局指标

主要结局

Vaginal delivery

时间窗: Variable, but within 4 days

Successful induction defined as a vaginal delivery following labor induction.

次要结局

  • Completed cervical ripening(2 days)
  • Rate of tachysystole, fetal nonreassuring status, uterine rupture(3 days)
  • Specific time interval from start of induction to active labor(2 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Carri Warshak

Associate Clinical Professor

University of Cincinnati

相似试验